PDB59 EVALUATING THE COST-UTILITY OF ADDING SODIUM-GLUCOSE COTRANSPORTER INHIBITORS TO A BASAL-BOLUS INSULIN REGIMEN IN PATIENTS WITH TYPE 1 DIABETES IN THE UK: AN ANALYSIS USING THE PRIME DIABETES MODEL

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.941
https://www.valueinhealthjournal.com/article/S1098-3015(19)33319-4/fulltext
Title : PDB59 EVALUATING THE COST-UTILITY OF ADDING SODIUM-GLUCOSE COTRANSPORTER INHIBITORS TO A BASAL-BOLUS INSULIN REGIMEN IN PATIENTS WITH TYPE 1 DIABETES IN THE UK: AN ANALYSIS USING THE PRIME DIABETES MODEL
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33319-4&doi=10.1016/j.jval.2019.09.941
First page :
Section Title :
Open access? : No
Section Order : 10832
Categories :
Tags :
Regions :
ViH Article Tags :